NCT02150616 Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Breathing and Sleep Status UNKNOWN Phase PHASE4
NCT02143687 Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance Status COMPLETED Phase PHASE4
NCT02136394 The Role of Gastroesophageal Reflux in Scleroderma Pulmonary Fibrosis Status UNKNOWN Phase N/A
NCT02075762 Comparison of Transbronchial, Cryoprobe, and VATS Biopsy for the Diagnosis of Interstitial Lung Disease Status COMPLETED Phase NA
NCT02036970 Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT Status COMPLETED Phase PHASE2
NCT02019641 The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease Status COMPLETED Phase NA
NCT01972685 Comparison of Transbronchial, Cryoprobe and VATS Biopsy For the Diagnosis of Interstitial Lung Disease (ILD) Status COMPLETED Phase NA
NCT01955824 A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy Status COMPLETED Phase PHASE2/PHASE3
NCT01894113 Prospective, Randomised Multicenter Study Comparing the Efficacy of Transbronchial Forceps Biopsy With Cryobiopsy to Diagnose Interstitial Lung Disease. Status COMPLETED Phase NA
NCT01874223 Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF Status COMPLETED Phase N/A
NCT01862926 Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD Status COMPLETED Phase PHASE2/PHASE3
NCT01809574 The Role of Rheumatological Evaluation in the Management of Patients With Interstitial Lung Disease Status UNKNOWN Phase N/A
NCT01714518 Cryobiopsy vs. VATS in Diagnosis of Interstitial Lung Diseases Status COMPLETED Phase N/A
NCT01713413 Effects of an Oxymizer on Endurance Time in Patients With Chronic Lung Diseases Status COMPLETED Phase NA
NCT01600352 Specific Autoantibody Testing in Patients With Interstitial Lung Disease Status COMPLETED Phase N/A
NCT01570764 Cyclophosphamide Systemic Sclerosis Associated Interstitial Lung Disease Status COMPLETED Phase PHASE3
NCT01559129 Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease Status TERMINATED Phase PHASE2